• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

STAT magazine article re Brett Saunders CEO

Quote

<











He has got to go down as one of the worst pharma CEO in history. So many missed opportunities.

Not to mention burning any and all goodwill that Allergan ever had at the stake.
 




Saunders is just happy that headlines don’t read:

“David Tepper of Appoloosa gets Brent Saunders head on a Pike”


In a way he did, but it would have been more satisfying if Tepper had forced him out, given more time he would have prevailed. The sale to Abbvie is as close as Saunders could get to an exit strategy. He still has egg on his face but at least he’s not covered in shit. Too bad it will cost the rest of us our paychecks.
 








how much does he make off of this deal? $300 mil? Amazing That they kept him around after that whole Indian reservation debacle. But I would sell you my reputation for 300 million any day of the week
 












anonymous said:
He has got to go down as one of the worst pharma CEO in history. So many missed opportunities.

Not to mention burning any and all goodwill that Allergan ever had at the stake.
Click to expand...

You know what is sad???

He is leading Allergan in a sale (not a merger) to Abbvie....where Allergan will soon be forgotten forever.

Due to the sale of Allergan to Abbvie, hundreds if not thousands of Allergan/Actavis/Watson/Forest employees will be laid off and jobless.

Brett Saunders will receive a fat "golden parachute" because of his time at Allergan.

Brett Saunders will become the CEO of another (much smaller) pharma company within 2 years of the Allergan - Abbvie deal closing.

Any thoughts?
 




anonymous said:
You know what is sad???

He is leading Allergan in a sale (not a merger) to Abbvie....where Allergan will soon be forgotten forever.

Due to the sale of Allergan to Abbvie, hundreds if not thousands of Allergan/Actavis/Watson/Forest employees will be laid off and jobless.

Brett Saunders will receive a fat "golden parachute" because of his time at Allergan.

Brett Saunders will become the CEO of another (much smaller) pharma company within 2 years of the Allergan - Abbvie deal closing.

Any thoughts?
Click to expand...

His name is Brent.
 




anonymous said:
You know what is sad???

He is leading Allergan in a sale (not a merger) to Abbvie....where Allergan will soon be forgotten forever.

Due to the sale of Allergan to Abbvie, hundreds if not thousands of Allergan/Actavis/Watson/Forest employees will be laid off and jobless.

Brett Saunders will receive a fat "golden parachute" because of his time at Allergan.

Brett Saunders will become the CEO of another (much smaller) pharma company within 2 years of the Allergan - Abbvie deal closing.

Any thoughts?
Click to expand...


Uh, Allergan and Botox will keep those names. It’s everyone that has nothing to do with Botox that will be gone and forgotten forever.
 
















Bizarro world

Saunders likely isn't bemoaning his Allergan payout, he's not quite where he might have been had Pfizer's proposed $160 billion buyout of the Dublin drugmaker not succumbed in 2016 under new U.S. tax rules. After heading up Forest Labs and then its buyer Actavis, Saunders took the helm of the combined Allergan-Actavis after the two merged. Many assumed that a Pfizer Allergan buy would put Saunders in line to succeed Pfizer's Ian Read—a job that ultimately went to Pfizer COO Albert Bourla.

Allergan CEO Saunders lines up for $39M parachute after AbbVie buy
 




Similar threads

Offensive WSJ article "Allergan Tries the 'Jewish Dentist' Defense
Replies
6
Views
4K
Allergan
Anonymous
Wall St article shows that Allergan can delay into 2015
Replies
3
Views
3K
Allergan
Anonymous
Top Bottom
Back
Quote